141 related articles for article (PubMed ID: 37680968)
61. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S
Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619
[TBL] [Abstract][Full Text] [Related]
62. Retinol-binding protein 4 mRNA translation in hepatocytes is enhanced by activation of mTORC1.
Welles JE; Toro AL; Sunilkumar S; Stevens SA; Purnell CJ; Kimball SR; Dennis MD
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E306-E315. PubMed ID: 33284085
[TBL] [Abstract][Full Text] [Related]
63. L-serine deficiency caused by genetic Phgdh deletion leads to robust induction of 4E-BP1 and subsequent repression of translation initiation in the developing central nervous system.
Sayano T; Kawakami Y; Kusada W; Suzuki T; Kawano Y; Watanabe A; Takashima K; Arimoto Y; Esaki K; Wada A; Yoshizawa F; Watanabe M; Okamoto M; Hirabayashi Y; Furuya S
FEBS J; 2013 Mar; 280(6):1502-17. PubMed ID: 23350942
[TBL] [Abstract][Full Text] [Related]
64. Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn.
Xu JT; Zhao X; Yaster M; Tao YX
Brain Res; 2010 Jun; 1336():46-57. PubMed ID: 20399760
[TBL] [Abstract][Full Text] [Related]
65. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
66. Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.
Gong X; Zhang L; Huang T; Lin TV; Miyares L; Wen J; Hsieh L; Bordey A
Hum Mol Genet; 2015 Oct; 24(20):5746-58. PubMed ID: 26220974
[TBL] [Abstract][Full Text] [Related]
67. Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells.
Guan L; Song K; Pysz MA; Curry KJ; Hizli AA; Danielpour D; Black AR; Black JD
J Biol Chem; 2007 May; 282(19):14213-25. PubMed ID: 17360714
[TBL] [Abstract][Full Text] [Related]
68. Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.
Tsukumo Y; Alain T; Fonseca BD; Nadon R; Sonenberg N
Nat Commun; 2016 Jun; 7():11776. PubMed ID: 27319316
[TBL] [Abstract][Full Text] [Related]
69. 4E-BP1 and 4E-BP2 double knockout mice are protected from aging-associated sarcopenia.
Le Bacquer O; Combe K; Patrac V; Ingram B; Combaret L; Dardevet D; Montaurier C; Salles J; Giraudet C; Guillet C; Sonenberg N; Boirie Y; Walrand S
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):696-709. PubMed ID: 30927336
[TBL] [Abstract][Full Text] [Related]
70. Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation.
Velásquez C; Cheng E; Shuda M; Lee-Oesterreich PJ; Pogge von Strandmann L; Gritsenko MA; Jacobs JM; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8466-71. PubMed ID: 27402756
[TBL] [Abstract][Full Text] [Related]
71. Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration.
Graber TG; Fry CS; Brightwell CR; Moro T; Maroto R; Bhattarai N; Porter C; Wakamiya M; Rasmussen BB
J Biol Chem; 2019 Mar; 294(11):4091-4102. PubMed ID: 30635399
[TBL] [Abstract][Full Text] [Related]
72. The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets.
Maracci C; Motta S; Romagnoli A; Costantino M; Perego P; Di Marino D
Curr Med Chem; 2022; 29(20):3501-3529. PubMed ID: 35209811
[TBL] [Abstract][Full Text] [Related]
73. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
Wang Z; Feng X; Molinolo AA; Martin D; Vitale-Cross L; Nohata N; Ando M; Wahba A; Amornphimoltham P; Wu X; Gilardi M; Allevato M; Wu V; Steffen DJ; Tofilon P; Sonenberg N; Califano J; Chen Q; Lippman SM; Gutkind JS
Cancer Res; 2019 Apr; 79(7):1438-1450. PubMed ID: 30894372
[TBL] [Abstract][Full Text] [Related]
74. Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex.
Kim SH; Yu HS; Huh S; Kang UG; Kim YS
Psychopharmacology (Berl); 2022 Feb; 239(2):443-454. PubMed ID: 34716784
[TBL] [Abstract][Full Text] [Related]
75. mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to regulate neural stem cell self-renewal in vivo.
Hartman NW; Lin TV; Zhang L; Paquelet GE; Feliciano DM; Bordey A
Cell Rep; 2013 Oct; 5(2):433-44. PubMed ID: 24139800
[TBL] [Abstract][Full Text] [Related]
76. Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis.
Dumstorf CA; Konicek BW; McNulty AM; Parsons SH; Furic L; Sonenberg N; Graff JR
Mol Cancer Ther; 2010 Dec; 9(12):3158-63. PubMed ID: 20971826
[TBL] [Abstract][Full Text] [Related]
77. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
78. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
79. The Translational Repressor 4E-BP1 Contributes to Diabetes-Induced Visual Dysfunction.
Miller WP; Mihailescu ML; Yang C; Barber AJ; Kimball SR; Jefferson LS; Dennis MD
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1327-37. PubMed ID: 26998719
[TBL] [Abstract][Full Text] [Related]
80. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L
Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
